Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 5,833 |
|
|||||
| News | - | ||||||
| Day High | 2.34 | Low High |
|||||
| Day Low | 1.92 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProMIS Neurosciences Inc | PMN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0499 | -2.50% | 1.95 | 16:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.92 | 1.92 | 2.34 | 1.95 | 1.9999 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 34 | 5,833 | $ 2.07 | $ 12,069 | - | 0.95 - 8.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 90 | $ 2.01 | USD |
ProMIS Neurosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 857.93k | 8.58M | - | 0 | -13.21M | -1.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProMIS Neurosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PMN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.27 | 2.4499 | 1.63 | 2.02 | 19,059 | -0.32 | -14.10% |
| 1 Month | 1.87 | 2.61 | 1.63 | 2.15 | 18,504 | 0.08 | 4.28% |
| 3 Months | 1.94 | 2.61 | 1.46 | 2.06 | 19,204 | 0.01 | 0.52% |
| 6 Months | 1.8242 | 3.10 | 0.95 | 1.98 | 32,075 | 0.1258 | 6.90% |
| 1 Year | 5.10 | 8.95 | 0.95 | 4.33 | 109,464 | -3.15 | -61.76% |
| 3 Years | 6.94 | 9.80 | 0.95 | 4.37 | 62,686 | -4.99 | -71.90% |
| 5 Years | 6.94 | 9.80 | 0.95 | 4.37 | 62,686 | -4.99 | -71.90% |
ProMIS Neurosciences Description
| ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada. |
